4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0000921895-23-002167
Director bought 1,505,932 shares at $9.84 ($14,818,371)
- Director acquired 99,556 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL Director | 2023-09-12 | Purchase | +775,278 | $9.84 | $7,628,736 | 4,688,954 | D: show line 1 in the form |
| BVF PARTNERS L P/IL Director | 2023-09-12 | Purchase | +677,853 | $9.84 | $6,670,074 | 3,584,512 | D: show line 2 in the form |
| BVF PARTNERS L P/IL Director | 2023-09-12 | Purchase | +52,801 | $9.84 | $519,562 | 524,151 | D: show line 3 in the form |
| BVF PARTNERS L P/IL Director | 2023-09-14 | Other acquisition | +99,556 | 99,556 | I: show line 4 in the form | ||
| Open-market purchases · 1,505,932 sh · avg $9.84 · $14,818,371 | |||||||
Loading xslF345X05/form407422olma_09142023.xml…